HIV-1 and AIDS: what are protective immune responses?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of HIV therapy

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12553686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• HIV extracellular Tat: myth or reality?

  2015cites this paper
• Update on mucosal HIV vaccine vectors

  2010cites this paper
• Repeated Rectal SHIVSF162P3 Exposures Do Not Consistently Induce Sustained T Cell Responses Prior to Systemic Infection in the Repeat-Low Dose Preclinical Macaque Model

  2009cites this paper
• HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development

  2009cites this paper
• Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

  2007cites this paper
• Perinatal Brain Damage Causation

  2007cites this paper
• Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+ T-Cell Responses in Mice

  2007cites this paper
• Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.

  2007cites this paper
• Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function.

  2007cites this paper
• Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine

  2006cites this paper
• Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.

  2006cites this paper
• CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.

  2005cites this paper
• Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy

  2004cites this paper
• Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes

  2004cites this paper
• HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)

  2004cites this paper
• RNA interference: The molecular immune system

  2004cites this paper
• Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level.

  2004cites this paper